Hodgkin Lymphoma News
- EHA 2022 A New First-line Regimen for Advanced Hodgkin Lymphoma?
- ASCO 2022 Enhertu Benefit in HER2-Low Breast Cancer: 'Practice Changing'
- Woman Who Faked Cancer Gets 5 Years in Prison
- Overlooked: Black Woman Doctor's Key Role in Oncology History
- Risk of Dying From New Cancer Higher in Young Cancer Survivors
- Alert FDA OKs Trastuzumab Deruxtecan for Earlier Use in Breast Cancer
- ESMO BCC 2022 'No Discernible Benefit' Adding Nivolumab to ADC in Breast Cancer
- 'Unprecedented Crisis': Hodgkin Drug Shortage Persists
- High Suicide, Depression Risks for Patients With Cancer
- Mother and Baby Fine After First Reported Use of Immune-checkpoint Inhibitor During Pregnancy
- When ImmunoTx Fails, HL Patients Should Get Timely Allo-HCT
- Survivor's Story Foreshadows One of Oncology's Greatest Successes
- Can Cancer Blood Tests Live Up to Promise of Saving Lives?
- AACR 2022 'Truly Impressive' Responses in Lymphoma With Novel Cell Therapy
- Ethnic Disparities in Cancer Incidence: First New Data in 10 Years
- Breast Cancer Trials Enrolling Now: Could Your Patient Benefit?
- Vitiligo From Checkpoint Inhibitors Not Limited to Melanoma
- 'New Standard of Care' for HER2-Mutant NSCLC?
- New Combo Therapy for Breast Implant–Associated Lymphoma
- ASH 2021 Novel Agents for Adult ALL: Is it Curtains for Chemo?